Literature DB >> 30905394

A biological or a synthetic mesh in immediate breast reconstruction? A cohort-study of long-term Health related Quality of Life (HrQoL).

Håkan Hallberg1, Anna Elander2, Lars Kölby2, Emma Hansson3.   

Abstract

OBJECTIVES: Meshes/matrices are commonly used in immediate breast reconstruction. There are few studies comparing biological and synthetic meshes and it is unknown what type of mesh gives the best long-term results. The aim of this study was to compare long-term health-related quality of life (HrQoL) and patient satisfaction in implant-based immediate breast reconstruction with a biological mesh (Surgisis®) with that of patients reconstructed with a synthetic mesh (TIGR ® Matrix Surgical Mesh).
MATERIAL AND METHODS: Both cohorts were prospectively included and consecutively operated. Clinical data was collected. HrQoL was evaluated with EuroQoL-5 dimension - 3 levels questionnaire (EQ-5D-3L) and the Hospital Anxiety and Depression Scale (HADS) and the Breast-Q. RESULTS AND
CONCLUSION: Seventy-one patients were operated on in the biological group and 49 in the synthetic group. The response rates were 75 and 84 per cent, respectively. Mean follow-up time was 74 months and 23 months, respectively. There were no statistical differences in satisfaction and quality of life between the two groups. Complications and radiation seem to lead to a lower satisfaction. Our findings could indicate that biological and synthetic meshes give an equal long-term result as regards patients' perceived quality of life.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Acellular dermal matrix; Immediate breast reconstruction; Implant; Patient's satisfaction; Quality of life; Synthetic mesh; Tissue expander

Mesh:

Substances:

Year:  2019        PMID: 30905394     DOI: 10.1016/j.ejso.2019.03.013

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  2 in total

1.  Patient-reported outcomes of ductoscopy procedures for pathologic nipple discharge.

Authors:  M D Filipe; J M Simons; L Moeliker; L Waaijer; M R Vriens; P J van Diest; A J Witkamp
Journal:  Breast Cancer       Date:  2020-11-12       Impact factor: 4.239

2.  First-year complications after immediate breast reconstruction with a biological and a synthetic mesh in the same patient: A randomized controlled study.

Authors:  Emma Hansson; Ann-Chatrin Edvinsson; Anna Elander; Lars Kölby; Håkan Hallberg
Journal:  J Surg Oncol       Date:  2020-10-13       Impact factor: 3.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.